• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
UT Shield
Mulva Clinic for the Neurosciences
  • About
    • Leadership
    • Departments
      • Neurology
        • 5th Anniversary Report
      • Neurosurgery
      • Psychiatry & Behavioral Sciences
        • Annual Report
  • Research Areas
    • Aging & Neurodegenerative Diseases
    • Neuroinflamation & Neuroimmunology
    • Brain & Nervous System Injury
    • Development & Neuroplasticity
    • Addiction
    • Neurosurgery
    • PTSD
    • Mood Disorders
    • Neural Engineering & Data Sciences
  • Research Labs & Centers
  • Clinical Trials
  • Clinical Services
    • UT Health Austin Adult
    • UT Health Austin Pediatric Neurosciences
    • UT Health Austin Pediatric Psychiatry
  • News

Research Focus

August 30, 2022, Filed Under: News

Psychedelic Drug Helped People With Alcohol Use Disorder Reduce Drinking, Study Shows

Greg Fonzo, co-director of the Center for Psychedelic Research & Therapy, and other experts weigh in on how psychedelics can be a “game changer” in treating certain complex conditions, like addiction. Read more at nbc news 

Primary Sidebar

Latest News

  • Five Faculty Members Promoted May 29, 2026
  • Register Now: Third Annual IMPRES Pediatric Research in Epilepsy Surgery Conference May 20, 2026
  • Fonzo and Melamed Promoted to Associate Professor April 19, 2026
  • Fonzo Team Recognized as Leading Research Achievement by the Brain and Behavior Research Foundation March 24, 2026
  • $1.45 Million Dementia Initiative Receives Continued Funding March 16, 2026
  • Howard & Brumback Study How Brain Circuit Processing Is Altered in Neurodevelopmental Disorders February 23, 2026

Footer

Contact us

UT Home | Emergency Information | Site Policies | Web Accessibility | Web Privacy | Adobe Reader

© The University of Texas at Austin 2026